Format

Send to

Choose Destination
BMC Health Serv Res. 2019 Apr 1;19(1):207. doi: 10.1186/s12913-019-4038-9.

Pharmacists expand access to reproductive heaLthcare: PEARL study protocol.

Author information

1
Department of Obstetrics and Gynecology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, UHN 50, Portland, OR, 97239, USA. rodrigma@ohsu.edu.
2
Department of Obstetrics and Gynecology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, UHN 50, Portland, OR, 97239, USA.
3
Center for Health Systems Effectiveness, Oregon Health &Science University, Portland, USA.
4
College of Pharmacy, Oregon State University, Corvallis, USA.

Abstract

BACKGROUND:

In 2016, Oregon became the first of eight states to allow pharmacists to directly prescribe hormonal contraception (HC), including the pill, patch, or ring, without a clinic visit. In the two years following this policy change, the majority of ZIP codes across the state of Oregon had a pharmacist certified to prescribe HC.

METHODS:

We will utilize complementary methodologies to evaluate the effect of this policy change on convenient access to contraception (cost, supply dispensed), safety, contraceptive continuation and unintended pregnancy rates. We will conduct a prospective clinical cohort study to directly measure the impact of provider type on contraceptive continuation and to understand who is accessing hormonal contraception directly from pharmacists. We will concurrently conduct a retrospective analysis using medical claims data to evaluate the state-level effect of the policy. We will examine contraceptive continuation rates, incident pregnancy, and safety measures. The combination of these methodologies allows us to examine key woman-level factors, such as pregnancy intention and usual place of care, while also estimating the impact of the pharmacist prescription policy at the state level.

DISCUSSION:

Pharmacist prescription of HC is emerging nationally as a strategy to reduce unintended pregnancy. This study will provide data on the effect of this practice on convenient access to care, contraceptive safety and continuation rates.

KEYWORDS:

Access to care; Continuation; Hormonal contraception; Pharmacists

PMID:
30935394
PMCID:
PMC6444429
DOI:
10.1186/s12913-019-4038-9
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center